Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mercedes Robledo

Showing results (121-130 of 215) with videos related to

Pageof 22
Sort By:
Thyroid : Official Journal of the American Thyroid Association|April 24, 2014
VEGF, VEGFR3, and PDGFRB protein expression is influenced by RAS mutations in medullary thyroid carcinomaVeronika Mancikova, Lucía Inglada-Pérez, Maria Curras-Freixes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathyMaría Apellániz-Ruiz, Mi-Young Lee, Lara Sánchez-Barroso, et al.
The Journal of Clinical Endocrinology and Metabolism|November 23, 2017
Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid CancerEsther N Klein Hesselink, Carles Zafon, Núria Villalmanzo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2020
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcomeJuan María Roldan-Romero, María Santos, Javier Lanillos, et al.
Molecular Biomedicine|April 2, 2026
Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomasVíctor García-Vioque, Sergio Pedraza-Arevalo, María Trinidad Moreno-Montilla, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2009
Genetics of pheochromocytoma and paraganglioma in Spanish patientsAlberto Cascón, Guillermo Pita, Nelly Burnichon, et al.
Journal of Medical Genetics|August 28, 2021
International initiative for a curated <i>SDHB</i> variant database improving the diagnosis of hereditary paraganglioma and pheochromocytomaLaurene Ben Aim, Eamonn R Maher, Alberto Cascon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 28, 2018
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paragangliomaSusan Richter, Laura Gieldon, Ying Pang, et al.
Endocrine-Related Cancer|September 17, 2008
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutationIoana N Milos, Karin Frank-Raue, Nelson Wohllk, et al.
Cancers|June 20, 2019
Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research ApproachesLaura Gieldon, Doreen William, Karl Hackmann, et al.
Pageof 22

Showing results (121-130 of 215) with videos related to

Sort By:
Pageof 22
Thyroid : Official Journal of the American Thyroid Association|April 24, 2014
VEGF, VEGFR3, and PDGFRB protein expression is influenced by RAS mutations in medullary thyroid carcinomaVeronika Mancikova, Lucía Inglada-Pérez, Maria Curras-Freixes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2014
Whole-exome sequencing reveals defective CYP3A4 variants predictive of paclitaxel dose-limiting neuropathyMaría Apellániz-Ruiz, Mi-Young Lee, Lara Sánchez-Barroso, et al.
The Journal of Clinical Endocrinology and Metabolism|November 23, 2017
Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid CancerEsther N Klein Hesselink, Carles Zafon, Núria Villalmanzo, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 4, 2020
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcomeJuan María Roldan-Romero, María Santos, Javier Lanillos, et al.
Molecular Biomedicine|April 2, 2026
Functional profiling of somatostatin receptors identifies somatostatin receptor subtype 2 as a vulnerability in Succinate Dehydrogenase SDHB-deficient pheochromocytomas and paragangliomasVíctor García-Vioque, Sergio Pedraza-Arevalo, María Trinidad Moreno-Montilla, et al.
The Journal of Clinical Endocrinology and Metabolism|March 5, 2009
Genetics of pheochromocytoma and paraganglioma in Spanish patientsAlberto Cascón, Guillermo Pita, Nelly Burnichon, et al.
Journal of Medical Genetics|August 28, 2021
International initiative for a curated <i>SDHB</i> variant database improving the diagnosis of hereditary paraganglioma and pheochromocytomaLaurene Ben Aim, Eamonn R Maher, Alberto Cascon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 28, 2018
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paragangliomaSusan Richter, Laura Gieldon, Ying Pang, et al.
Endocrine-Related Cancer|September 17, 2008
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutationIoana N Milos, Karin Frank-Raue, Nelson Wohllk, et al.
Cancers|June 20, 2019
Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research ApproachesLaura Gieldon, Doreen William, Karl Hackmann, et al.
Pageof 22